BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 12837698)

  • 81. The homeobox transcription factor Barx2 regulates chondrogenesis during limb development.
    Meech R; Edelman DB; Jones FS; Makarenkova HP
    Development; 2005 May; 132(9):2135-46. PubMed ID: 15800003
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Heterozygous SOX9 mutations allowing for residual DNA-binding and transcriptional activation lead to the acampomelic variant of campomelic dysplasia.
    Staffler A; Hammel M; Wahlbuhl M; Bidlingmaier C; Flemmer AW; Pagel P; Nicolai T; Wegner M; Holzinger A
    Hum Mutat; 2010 Jun; 31(6):E1436-44. PubMed ID: 20513132
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical, genetics and bioinformatics characterization of a campomelic dysplasia case report.
    Carvajal N; Martínez-García M; Chagoyen M; Morcillo N; Pino A; Lorda I; Trujillo-Tiebas MJ
    Gene; 2016 Feb; 577(2):289-92. PubMed ID: 26631621
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The transcription factors steroidogenic factor-1 and SOX9 regulate expression of Vanin-1 during mouse testis development.
    Wilson MJ; Jeyasuria P; Parker KL; Koopman P
    J Biol Chem; 2005 Feb; 280(7):5917-23. PubMed ID: 15590666
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [The genetics of sex determination].
    Vialard F; Fellous M
    J Soc Biol; 2002; 196(3):197-205. PubMed ID: 12462073
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Copy number variation of two separate regulatory regions upstream of SOX9 causes isolated 46,XY or 46,XX disorder of sex development.
    Kim GJ; Sock E; Buchberger A; Just W; Denzer F; Hoepffner W; German J; Cole T; Mann J; Seguin JH; Zipf W; Costigan C; Schmiady H; Rostásy M; Kramer M; Kaltenbach S; Rösler B; Georg I; Troppmann E; Teichmann AC; Salfelder A; Widholz SA; Wieacker P; Hiort O; Camerino G; Radi O; Wegner M; Arnold HH; Scherer G
    J Med Genet; 2015 Apr; 52(4):240-7. PubMed ID: 25604083
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mutant NR5A1/SF-1 in patients with disorders of sex development shows defective activation of the SOX9 TESCO enhancer.
    Sreenivasan R; Ludbrook L; Fisher B; Declosmenil F; Knower KC; Croft B; Bird AD; Ryan J; Bashamboo A; Sinclair AH; Koopman P; McElreavey K; Poulat F; Harley VR
    Hum Mutat; 2018 Dec; 39(12):1861-1874. PubMed ID: 30067310
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Toward understanding SOX9 function in chondrocyte differentiation.
    Lefebvre V; de Crombrugghe B
    Matrix Biol; 1998 Mar; 16(9):529-40. PubMed ID: 9569122
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Unraveling the transcriptional regulatory machinery in chondrogenesis.
    Akiyama H; Lefebvre V
    J Bone Miner Metab; 2011 Jul; 29(4):390-5. PubMed ID: 21594584
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia.
    Velagaleti GV; Bien-Willner GA; Northup JK; Lockhart LH; Hawkins JC; Jalal SM; Withers M; Lupski JR; Stankiewicz P
    Am J Hum Genet; 2005 Apr; 76(4):652-62. PubMed ID: 15726498
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Paraspeckle protein p54nrb links Sox9-mediated transcription with RNA processing during chondrogenesis in mice.
    Hata K; Nishimura R; Muramatsu S; Matsuda A; Matsubara T; Amano K; Ikeda F; Harley VR; Yoneda T
    J Clin Invest; 2008 Sep; 118(9):3098-108. PubMed ID: 18677406
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia.
    Piper K; Ball SG; Keeling JW; Mansoor S; Wilson DI; Hanley NA
    Mech Dev; 2002 Aug; 116(1-2):223-6. PubMed ID: 12128229
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development.
    Arango NA; Lovell-Badge R; Behringer RR
    Cell; 1999 Nov; 99(4):409-19. PubMed ID: 10571183
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Translocation breakpoints in three patients with campomelic dysplasia and autosomal sex reversal map more than 130 kb from SOX9.
    Wirth J; Wagner T; Meyer J; Pfeiffer RA; Tietze HU; Schempp W; Scherer G
    Hum Genet; 1996 Feb; 97(2):186-93. PubMed ID: 8566951
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Aetiology of the skeletal dysmorphology syndrome campomelic dysplasia: expression of the Sox9 gene during chondrogenesis in mouse embryos.
    Wheatley S; Wright E; Jeske Y; MCCormack A; Bowles J; Koopman P
    Ann N Y Acad Sci; 1996 Jun; 785():350-2. PubMed ID: 8702178
    [No Abstract]   [Full Text] [Related]  

  • 96. Heterozygous deletion of Sox9 in mouse mimics the gonadal sex reversal phenotype associated with campomelic dysplasia in humans.
    Bagheri-Fam S; Combes AN; Ling CK; Wilhelm D
    Hum Mol Genet; 2021 Feb; 29(23):3781-3792. PubMed ID: 33305798
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A novel sex-determining region on Y (SRY) missense mutation identified in a 46,XY female and also in the father.
    Imai A; Takagi A; Tamaya T
    Endocr J; 1999 Oct; 46(5):735-9. PubMed ID: 10670762
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The dimerization domain of SOX9 is required for transcription activation of a chondrocyte-specific chromatin DNA template.
    Coustry F; Oh CD; Hattori T; Maity SN; de Crombrugghe B; Yasuda H
    Nucleic Acids Res; 2010 Oct; 38(18):6018-28. PubMed ID: 20484372
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Novel SRY-box transcription factor 9 variant in campomelic dysplasia and the location of missense and nonsense variants along the protein domains: A case report.
    Calvache CA; Vásquez EC; Romero VI; Hosomichi K; Pozo JC
    Front Pediatr; 2022; 10():975947. PubMed ID: 36467484
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Basic helix-loop-helix transcription factor Twist1 inhibits transactivator function of master chondrogenic regulator Sox9.
    Gu S; Boyer TG; Naski MC
    J Biol Chem; 2012 Jun; 287(25):21082-92. PubMed ID: 22532563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.